MSD SVP Deepak Khanna: Taking a Europe-Wide Approach in the Fight Against Cancer
There are over 3.5 million diagnoses and 1.3 million deaths from cancer in the EU each year and cancer is set to become the region’s leading cause of death without…
Address: Essenscia Diamant Building Bd A. Reyers 80 1030 Brussels, Belgium
Tel: +32 (0)2 238 97 11
essenscia is a multisectoral umbrella organisation that represents the numerous sectors of activities in the field of chemicals and the life sciences. It includes nearly 800 companies representing more than 95% of the overall turnover in the sector.
The structure of essenscia is modelled on the reality of the Belgian institutions, with federal, regional and community areas of competence. essenscia bruxelles, essenscia vlaanderen and essenscia wallonie, the three regional sections of essenscia, act as spokesmen for companies to the Brussels, Flemish and Walloon authorities on regional and community matters. essenscia is made up of multidisciplinary skills centres which also deal with the main issues, irrespective of the level of power. The 17 professional sections of essenscia represent and promote interests specific to their sector of activities.
essenscia represents and defends the sector’s interests at a European level through active involvement in Cefic (the European Council of Chemical Manufacturers’ Federations) and the FEB (Federation of Belgian Companies).
There are over 3.5 million diagnoses and 1.3 million deaths from cancer in the EU each year and cancer is set to become the region’s leading cause of death without…
Joris Van Assche, managing director of the Belgian association for accessible medicines, Medaxes, highlights the need for a stronger policy to create a more positive environment for generic and biosimilar…
Speaking at the 2020 European Cancer Forum in Brussels, MSD’s Deepak Khanna outlines the progress that the company is making at the forefront of oncological innovation, the importance of multi-stakeholder…
After reaching revenues of EUR 2.323 billion in the first six months of 2019, UCB announced on December 18 that it will build an innovative multi-product biological manufacturing facility on…
The second edition of the European Cancer Forum was held in Brussels, Belgium on Tuesday, 29 January 2020. Hosted by MSD in collaboration with the European Cancer Patient Coalition (ECPC),…
Jean-Christophe Tellier became UCB’s CEO on January 1, 2015 only a few years joining the company in 2011. Before taking on the role Tellier held positions as executive VP of…
Annie Hubert, Senior Director, EU Section & Public Policy for the Alliance for Regenerative Medicine (ARM) describes some of the issues that companies in the advanced therapies field are facing…
One of NNE Pharmaplan’s latest exciting news is that last year you established offices to accommodate your existing customers in Belgium. What were the strategic motivations for establishing a presence…
Mr. Heyman, you inherited the chair and management of Janssen Pharmaceutica. What core values and spirit of Dr. Paul Janssen were you asked by the Janssen family to perpetuate throughout…
Mr. Heyman, you inherited the chair and management of Janssen Pharmaceutica. What core values and spirit of Dr. Paul Janssen were you asked by the Janssen family to perpetuate throughout…
Mrs van der Kamp, you launched your career as a strategy consultant however, since then you have moved into the pharmaceutical industry by joining Novartis where you quickly worked your…
With an expenditure of more than 10% of GDP on health, Belgium maintains one of the world’s leading healthcare systems. That said, could you please comment on the current state…
See our Cookie Privacy Policy Here
